Hillevax Inc
NASDAQ:HLVX
Hillevax Inc
Total Liabilities
Hillevax Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
H
|
Hillevax Inc
NASDAQ:HLVX
|
Total Liabilities
$78.9m
|
CAGR 3-Years
188%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities
$140.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities
$38.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities
$88B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities
$5.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Liabilities
$7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
See Also
What is Hillevax Inc's Total Liabilities?
Total Liabilities
78.9m
USD
Based on the financial report for Dec 31, 2023, Hillevax Inc's Total Liabilities amounts to 78.9m USD.
What is Hillevax Inc's Total Liabilities growth rate?
Total Liabilities CAGR 3Y
188%
Over the last year, the Total Liabilities growth was 58%. The average annual Total Liabilities growth rates for Hillevax Inc have been 188% over the past three years .